Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-142845
Filing Date
2024-05-20
Accepted
2024-05-20 16:11:46
Documents
5
Effectiveness Date
2024-05-20

Document Format Files

Seq Description Document Type Size
1 S-8 d847776ds8.htm S-8 43092
2 EX-5.1 d847776dex51.htm EX-5.1 8081
3 EX-23.1 d847776dex231.htm EX-23.1 1588
4 EX-FILING FEES d847776dexfilingfees.htm EX-FILING FEES 20048
5 GRAPHIC g847776dsp001a.jpg GRAPHIC 3078
  Complete submission text file 0001193125-24-142845.txt   78268
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279542 | Film No.: 24964574
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)